About Rampex Labs Private Limited
Data last updated: 22 December 2025
Rampex Labs Private Limited is a private limited company based in Bollaram Villege, Telangana, India. It specialises in api manufacturers, a part of the broader pharmaceuticals sector. Incorporated on 18 May 2004, the company has been in operation for over 22 years.
Registered with ROC Hyderabad under CIN U24239TG2004PTC043271.
Capital: an authorised share capital of ₹35 Cr and a paid-up capital of ₹26.69 Cr. It is led by directors including Jatinbhai Siddharthbhai Shah and Venkateswara Rao Ghattamaneni.
Last AGM: 26 September 2025. Financial statements filed for year ended 31 March 2025. Office: Plot No.151 S.V.Cooperative Industrial Estate Bollaram Villege Jinnaram Mandal, Telangana, India – 502325.
As per the financials filed for FY 2025, the company reported a revenue of ₹152.68 Cr, a growth of 16% compared to the previous year.
The company has a workforce of approximately 322 employees as per the latest available data.
The company is associated with 1 brand - Rampex Labs. As per MCA filings, the company has open charges of ₹68.66 Cr and satisfied charges of ₹69.11 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website rampexlabs.com.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media**************
-
Registered AddressPlot No.151 S.V.Cooperative Industrial Estate Bollaram Villege Jinnaram Mandal, Telangana, India – 502325
-
IndustryPharma, API Manufacturers
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Rampex Labs Private Limited
Rampex Labs Private Limited has one previous CIN (Corporate Identification Number): U24239AP2004PTC043271. The current CIN is U24239TG2004PTC043271, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TG2004PTC043271 | Current |
| U24239AP2004PTC043271 | Previous |
Associated Brands with Rampex Labs Private Limited
Rampex Labs Private Limited operates one associated brand: Rampex Labs. These brands represent Rampex Labs Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical intermediates for APIs are manufactured by Rampex Labs. | rampexlabs.com |
Business Activity of Rampex Labs Private Limited
Rampex Labs Private Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | ********* |
Auditor Details of Rampex Labs Private Limited
Auditor information for Rampex Labs Private Limited provides details about the firm responsible for auditing the company's financial statements and ensuring compliance with regulatory requirements.
Board of Directors of Rampex Labs Private Limited
Rampex Labs Private Limited is currently managed by 8 directors, with 10 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jatinbhai Siddharthbhai Shah | Director | 02 Sep 2021 | 4 Years 10 Months | Current |
| Venkateswara Rao Ghattamaneni | Whole-Time Director | 29 Sep 2022 | 3 Years 9 Months | Current |
| Surya Venkata Narasimha Sastry Jayanty | Whole-Time Director | 01 Apr 2008 | 18 Years 3 Months | Current |
|
Nishant Tiwary
Also directs:
South Atlantic Partners India Private Limited
|
Director | 01 Jul 2024 | 2 Years 0 Months | Current |
|
Maganti Murali
Also directs:
Kbm Properties Llp, Vani Plastics & Plantations Private Limited, Krishna Poly Packs Pvt Ltd and 3 more
|
Director | 07 Oct 2004 | 21 Years 9 Months | Current |
|
Lokanath Bolleni
Also directs:
Tukaram & Co Llp
|
Director | 07 Oct 2004 | 21 Years 9 Months | Current |
Financials of Rampex Labs Private Limited FY 2025 filings available
Rampex Labs Private Limited reported revenue of ₹152.68 Cr (up 16% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Shareholding Pattern of Rampex Labs Private Limited
As of FY 2023, Rampex Labs Private Limited's shareholding pattern shows 35.91% by promoters, 64.08% by public shareholders. Public shareholders hold the majority stake, reflecting broad public ownership.
| Year | 2025 |
|---|---|
| Promoters | 33.19% |
| DII | 23.22% |
| FII | 18.28% |
| Public | 22.89% |
| Others | 2.42% |
Charges & Borrowings of Rampex Labs Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Aug 2019 | Hdfc Bank Limited | ₹57.52 Cr | Open |
| 16 Feb 2019 | The South Indian Bank Limited | ₹11.14 Cr | Open |
| 01 Aug 2016 | Others | ₹4 Cr | Satisfied |
| 02 Apr 2007 | Others | ₹63.36 Cr | Satisfied |
| 12 Mar 2007 | Industrial Development Bank of India | ₹1.75 Cr | Satisfied |
Total charge records: 5 View all charges
Employees and EPFO Compliance at Rampex Labs Private Limited
Rampex Labs Private Limited has a workforce of 322 employees as of Apr 02, 2024.
Employee Count & EPFO Data of Rampex Labs Private Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Rampex Labs Private Limited
GSTIN & GST Filing Data of Rampex Labs Private Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Rampex Labs Private Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Rampex Labs Private Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Rampex Labs Private Limited
MSME Payment Delays by Rampex Labs Private Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Rampex Labs Private Limited
Subsidiaries & Group Companies of Rampex Labs Private Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Rampex Labs Private Limited with ownership details.
MCA Filings & Documents of Rampex Labs Private Limited
MCA Filings & Documents of Rampex Labs Private Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Rampex Labs Private Limited
Frequently Asked Questions about Rampex Labs Private Limited
Rampex Labs Private Limited is an active private limited company in the pharma sector based in Bollaram Villege, Telangana, India. It was incorporated on 18 May 2004 (22+ years old) and is registered under CIN U24239TG2004PTC043271. The company has 322 employees.
Rampex Labs Private Limited reported revenue of ₹152.68 Cr for FY 2025 (up 16.00% YoY).
The current directors of Rampex Labs Private Limited are:
The primary industry of Rampex Labs Private Limited is pharma. The company specifically operates in api manufacturers. The company is currently active in this sector.
Rampex Labs Private Limited can be reached at the registered office: Plot No.151 S.V.Cooperative Industrial Estate Bollaram Villege Jinnaram Mandal, Telangana, India – 502325, or through the website rampexlabs.com.
The authorised capital is ₹35 Cr, and the paid-up capital is ₹26.69 Cr.